# FDA Inspection 1303428 - Waylis Therapeutics - February 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/waylis-therapeutics/9556879f-5f81-4433-881b-59a74b649726
Source feed: FDA_Inspections

> FDA Inspection 1303428 for Waylis Therapeutics on February 12, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303428
- Company Name: Waylis Therapeutics
- Inspection Date: 2026-02-12
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: New Jersey District Office

Company: https://www.keypedia.com/companies/waylis-therapeutics/3d1c452a-fef8-4404-a314-dc9fb6038b9b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248